European Growth Stocks With Insider Ownership And Up To 14% Revenue Growth

In This Article:

In the midst of escalating trade tensions and market volatility, European indices have experienced fluctuations, with the pan-European STOXX Europe 600 Index ending lower as central banks heighten their vigilance. In such uncertain times, stocks that combine growth potential with high insider ownership can offer a compelling investment narrative, as they may align management interests with shareholder value while navigating economic challenges.

Top 10 Growth Companies With High Insider Ownership In Europe

Name

Insider Ownership

Earnings Growth

Pharma Mar (BME:PHM)

11.8%

40.8%

Vow (OB:VOW)

13.1%

111.2%

Bergen Carbon Solutions (OB:BCS)

12%

50.8%

Elicera Therapeutics (OM:ELIC)

20.5%

97.2%

Nordic Halibut (OB:NOHAL)

29.8%

60.7%

CD Projekt (WSE:CDR)

29.7%

37.4%

Xbrane Biopharma (OM:XBRANE)

20%

82.7%

Elliptic Laboratories (OB:ELABS)

22.6%

88.2%

Lokotech Group (OB:LOKO)

13.9%

58.1%

Ortoma (OM:ORT B)

27.7%

68.6%

Click here to see the full list of 217 stocks from our Fast Growing European Companies With High Insider Ownership screener.

We're going to check out a few of the best picks from our screener tool.

Basic-Fit

Simply Wall St Growth Rating: ★★★★★☆

Overview: Basic-Fit N.V., along with its subsidiaries, operates fitness clubs and has a market cap of approximately €1.23 billion.

Operations: The company's revenue segments include €522.10 million from Benelux and €693.10 million from France, Spain & Germany.

Insider Ownership: 12%

Revenue Growth Forecast: 11.3% p.a.

Basic-Fit has shown substantial growth, with earnings forecasted to grow significantly above the Dutch market average. It became profitable this year, reporting a net income of €8 million for 2024 compared to a loss previously. Despite its volatile share price and interest payments not well covered by earnings, Basic-Fit's revenue is growing faster than the market and its Return on Equity is expected to be high in three years. The company is considering a share repurchase program, potentially enhancing shareholder value.

ENXTAM:BFIT Ownership Breakdown as at Apr 2025
ENXTAM:BFIT Ownership Breakdown as at Apr 2025

Vimian Group

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Vimian Group AB (publ) operates in the animal health industry globally, with a market capitalization of SEK20.22 billion.

Operations: Vimian Group AB generates revenue from its Medtech segment (€123.90 million), Diagnostics (€20.90 million), Specialty Pharma (€172 million), and Veterinary Services (€58.20 million).